Obsessive-Compulsive Disorder – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Obsessive-Compulsive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder. Obsessive-Compulsive Disorder - Pipeline Review, Half Year ... \| read more...	$2,000.00
Human papillomavirus (HPV) Associated Cancer – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Human papillomavirus (HPV) Associated Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Skin Infections – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Skin Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Infections. Skin Infections - Pipeline Review, Half Year ... \| read more...	$2,000.00
Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... This report provides information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ... \| read more...	$2,000.00
Male Infertility – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Male Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Infertility. Male Infertility - Pipeline Review, Half Year ... \| read more...	$2,000.00
Respiratory Distress Syndrome – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Distress Syndrome. Respiratory Distress Syndrome ... \| read more...	$2,000.00
Dental Caries – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Dental Caries, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Caries. Dental Caries - Pipeline Review, Half Year ... \| read more...	$2,000.00
Heart Transplantation – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Heart Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Heart Transplantation. Heart Transplantation - Pipeline Review, Half Year ... \| read more...	$2,000.00
Infectitious Diarrhea – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Infectitious Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Infectitious Diarrhea. Infectitious Diarrhea - Pipeline Review, Half Year ... \| read more...	$2,000.00
Colorectal Cancer – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Colorectal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Colorectal Cancer. Colorectal Cancer - Pipeline Review, Half Year ... \| read more...	$2,000.00
Ragweed Allergy – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Ragweed Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ragweed Allergy. Ragweed Allergy - Pipeline Review, Half Year ... \| read more...	$2,000.00
Premenstrual Syndrome – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Premenstrual Syndrome. Premenstrual Syndrome - Pipeline Review, Half Year ... \| read more...	$2,000.00
Haemophilus Influenzae Infections – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic development for Haemophilus Influenzae Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Haemophilus Influenzae Infections. Haemophilus Influenzae Infections ... \| read more...	$2,000.00
Pulmonary Fibrosis – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Fibrosis. Pulmonary Fibrosis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Bone Fracture – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Bone Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Fracture. Bone Fracture - Pipeline Review, Half Year ... \| read more...	$2,000.00
Viral Conjunctivitis – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Viral Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Viral Conjunctivitis. Viral Conjunctivitis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Skin Cancer – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Skin Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Cancer. Skin Cancer - Pipeline Review, Half Year ... \| read more...	$2,500.00
Lung Injury – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Lung Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Injury. Lung Injury - Pipeline Review, Half Year ... \| read more...	$2,000.00
Grass Pollen Allergy – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic development for Grass Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Grass Pollen Allergy. Grass Pollen Allergy ... \| read more...	$2,000.00
MediPoint: Breast Cancer Imaging - EU Analysis and Market Forecasts 5/27/2013 \| published by: GlobalData ... in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates ... \| read more...	$4,450.00
Cardiovascular Risk Factors – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic development for Cardiovascular Risk Factors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Risk Factors. Cardiovascular Risk Factors ... \| read more...	$2,000.00
Gastric Cancer – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Gastric Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastric Cancer. Gastric Cancer - Pipeline Review, Half Year ... \| read more...	$2,000.00
West Nile Virus Infections – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... on the therapeutic development for West Nile Virus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for West Nile Virus ... \| read more...	$2,000.00
Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Allergic Rhino-Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Rhino-Conjunctivitis. Allergic Rhino-Conjunctivitis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Rubella – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rubella. Rubella - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00

< prev 1 2 3 4 5 6 7 8 9 10 next >